Local Administration of Carboplatin in Poloxamer 407 After an Ulnar Osteosarcoma Removal in a Dog

J Am Anim Hosp Assoc. 2020 Nov 1;56(6):325. doi: 10.5326/JAAHA-MS-6926.

Abstract

An 8 yr old male castrated hound presented for a left distal ulnar osteosarcoma. Staging (computed tomography and nuclear scintigraphy) did not reveal any metastases. A limb-sparing ulnectomy with local adjunctive carboplatin in a poloxamer copolymer gel (poloxamer 407) was performed. The patient recovered without complications after surgery. No wound healing complications or adverse effects occurred after local use of carboplatin in poloxamer 407. The local recurrence-free interval was 296 days from surgery, and the survival time was 445 days from initial diagnosis. This is the first report in the veterinary literature of using poloxamer 407 as a carrier for local delivery of chemotherapeutic drugs in a clinical patient.

Publication types

  • Case Reports

MeSH terms

  • Amputation, Surgical / veterinary
  • Animals
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use
  • Bone Neoplasms / therapy
  • Bone Neoplasms / veterinary*
  • Carboplatin / administration & dosage
  • Carboplatin / therapeutic use*
  • Dog Diseases / drug therapy*
  • Dogs
  • Forelimb / pathology*
  • Forelimb / surgery
  • Male
  • Neoplasm Recurrence, Local / surgery
  • Neoplasm Recurrence, Local / veterinary
  • Osteosarcoma / therapy
  • Osteosarcoma / veterinary*
  • Poloxamer / chemistry*

Substances

  • Antineoplastic Agents
  • Poloxamer
  • Carboplatin